XytriX

Umbilical cord-derived mesenchymal stem cells · TricelX Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XytriX, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis [Phase 1, Phase 2]

See pricing